Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jun;100(2):336–340. doi: 10.1111/j.1476-5381.1990.tb15805.x

Renal vascular responsiveness to arachidonic acid in experimental diabetes.

J Quilley 1, J C McGiff 1
PMCID: PMC1917432  PMID: 2116203

Abstract

1. Isolated perfused kidneys from diabetic rats (duration 4-6 and 20-24 weeks) were more sensitive to the vasoconstrictor effects of arachidonic acid than kidneys from age-matched control rats. Sensitivity diminished with age in both control and diabetic groups. 2. The enhanced vasoconstrictor effect of arachidonic acid in diabetic rat kidneys was associated with increased conversion to prostaglandins. 3. The renal vasoconstrictor response to arachidonic acid in both groups was reduced by thromboxane A2/prostaglandin H2 receptor antagonism but not by inhibition of thromboxane synthase. 4. Diabetic rat kidneys were also more sensitive to the vasoconstrictor effects of the endoperoxide analogue, U46619, while vasoconstrictor responses to phenylephrine were not markedly different from those of control rat kidneys. 5. In conclusion, prostaglandin endoperoxides appear to mediate arachidonic acid-induced vasoconstriction in diabetic and control rat kidneys. The enhanced renal vasoconstrictor response to arachidonic acid in diabetic rats results from increased sensitivity to endoperoxides and increased formation of endoperoxides from arachidonic acid.

Full text

PDF
336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boura A. L., Hodgson W. C., King R. G. Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid. Br J Pharmacol. 1986 Nov;89(3):613–618. doi: 10.1111/j.1476-5381.1986.tb11163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Halushka P. V., Rogers R. C., Loadholt C. B., Colwell J. A. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med. 1981 Jan;97(1):87–96. [PubMed] [Google Scholar]
  3. Harrison H. E., Reece A. H., Johnson M. Decreased vascular prostacyclin in experimental diabetes. Life Sci. 1978 Jul 24;23(4):351–355. doi: 10.1016/0024-3205(78)90020-6. [DOI] [PubMed] [Google Scholar]
  4. Johnson M., Harrison H. E., Raftery A. T., Elder J. B. Vascular prostacyclin may be reduced in diabetes in man. Lancet. 1979 Feb 10;1(8111):325–326. doi: 10.1016/s0140-6736(79)90737-2. [DOI] [PubMed] [Google Scholar]
  5. Quilley J., McGiff J. C. Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus. J Pharmacol Exp Ther. 1985 Jul;234(1):211–216. [PubMed] [Google Scholar]
  6. Quilley J., McGiff J. C., Nasjletti A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br J Pharmacol. 1989 Jan;96(1):111–116. doi: 10.1111/j.1476-5381.1989.tb11790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Roth D. M., Reibel D. K., Lefer A. M. Vascular responsiveness and eicosanoid production in diabetic rats. Diabetologia. 1983 May;24(5):372–376. doi: 10.1007/BF00251827. [DOI] [PubMed] [Google Scholar]
  8. Rösen P., Senger W., Feuerstein J., Grote H., Reinauer H., Schrör K. Influence of streptozotocin diabetes on myocardial lipids and prostaglandin release by the rat heart. Biochem Med. 1983 Aug;30(1):19–33. doi: 10.1016/0006-2944(83)90004-2. [DOI] [PubMed] [Google Scholar]
  9. Sarubbi D., McGiff J. C., Quilley J. Renal vascular responses and eicosanoid release in diabetic rats. Am J Physiol. 1989 Nov;257(5 Pt 2):F762–F768. doi: 10.1152/ajprenal.1989.257.5.F762. [DOI] [PubMed] [Google Scholar]
  10. Schambelan M., Blake S., Sraer J., Bens M., Nivez M. P., Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1985 Feb;75(2):404–412. doi: 10.1172/JCI111714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Subbiah M. T., Dietemeyer D. Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats. Biochem Med. 1980 Apr;23(2):231–235. doi: 10.1016/0006-2944(80)90076-9. [DOI] [PubMed] [Google Scholar]
  12. Valentovic M. A., Lubawy W. C. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats. Diabetes. 1983 Sep;32(9):846–851. doi: 10.2337/diab.32.9.846. [DOI] [PubMed] [Google Scholar]
  13. Ziboh V. A., Maruta H., Lord J., Cagle W. D., Lucky W. Increased biosynthesis of thromboxane A2 by diabetic platelets. Eur J Clin Invest. 1979 Jun;9(3):223–228. doi: 10.1111/j.1365-2362.1979.tb00927.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES